Oral diazoxide versus placebo for severe or recurrent neonatal hypoglycaemia: Neonatal Glucose Care Optimisation (NeoGluCO) study – a randomised controlled trial

Oral diazoxide versus placebo for severe or recurrent neonatal hypoglycaemia: Neonatal Glucose Care Optimisation (NeoGluCO) study – a randomised controlled trial

Introduction Infants with severe or recurrent transitional hypoglycaemia continue to have high rates of adverse neurological outcomes and new treatment approaches are needed that target the underlying pathophysiology. Diazoxide is one such treatment that acts on the pancreatic β-cell in a dose-depen...

Full description

Bibliographic Details
Main Authors: Jane E Harding, Wayne S Cutfield, J Geoffrey Chase, Jane M Alsweiler, Jenny Rogers, Julena Ardern, Greg D Gamble, Sara M Hanning, Michael P Meyer, Don Laing, Eamon Walsh, Christopher JD McKinlay
Format: Article
Language:English
Published: BMJ Publishing Group 2022-08-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/12/8/e059452.full

Internet

https://bmjopen.bmj.com/content/12/8/e059452.full

Similar Items